Literature DB >> 12532296

A three-component reaction for diversity-oriented synthesis of polysubstituted piperidines: solution and solid-phase optimization of the first tandem aza[4+2]/allylboration.

Barry B Touré1, Hamid R Hoveyda, Jyoti Tailor, Agnieszka Ulaczyk-Lesanko, Dennis G Hall.   

Abstract

This article describes the design and optimization of a simple three-component aza[4+2]/allylboration reaction to access polysubstituted alpha-hydroxyalkyl piperidines in a highly diastereocontrolled fashion from maleimides, 4-boronohydrazonodienes, and aldehydes. The aldehyde component does not interfere with the first aza[4+2] step, and it was found that this tandem reaction provides better yields of piperidine products 5 when carried out in one-pot. The required 4-borono-hydrazonodienes 1 are synthesized efficiently from the condensation of 3-boronoacrolein pinacol ester (4) with hydrazines. Overall, the three-component process using N-substituted maleimides as dienophiles produces four stereogenic centers and is quite general. It tolerates the use of a wide variety of aldehydes and hydrazine precursors with different electronic and steric characteristics. By allowing such a wide substrate scope and up to four elements of diversity, this reaction process is particularly well adapted towards applications in diversity-oriented synthesis of polysubstituted piperidine derivatives. The suitability of the aza[4+2]/allylboration reaction for use in solid-phase chemistry was also demonstrated using a N-arylmaleidobenzoic acid functionalized resin. This novel multicomponent reaction thus offers a high level of stereocontrol and versatility in the preparation of densely functionalized nitrogen heterocycles.

Entities:  

Year:  2003        PMID: 12532296     DOI: 10.1002/chem.200390049

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  7 in total

1.  In Vitro Metabolic Stability and in Vivo Biodistribution of 3-Methyl-4-furoxancarbaldehyde Using PET Imaging in Rats.

Authors:  Adam B Pippin; Zaira Hidayah Mohd Arshad; Ronald J Voll; Jonathon A Nye; Sussan Ghassabian; Craig M Williams; Alessandra Mancini; Dennis C Liotta; Maree T Smith; Mark M Goodman
Journal:  ACS Med Chem Lett       Date:  2016-03-30       Impact factor: 4.345

2.  Fluorous mixture synthesis of two libraries with hydantoin-, and benzodiazepinedione-fused heterocyclic scaffolds.

Authors:  Wei Zhang; Yimin Lu; Christine Hiu-Tung Chen; Lu Zeng; Daniel B Kassel
Journal:  J Comb Chem       Date:  2006 Sep-Oct

3.  Multistep synthesis of complex boronic acids from simple MIDA boronates.

Authors:  Eric P Gillis; Martin D Burke
Journal:  J Am Chem Soc       Date:  2008-10-07       Impact factor: 15.419

4.  Permuting Diels-Alder and Robinson Annulation Stereopatterns.

Authors:  Feng Peng; Mingji Dai; Angie R Angeles; Samuel J Danishefsky
Journal:  Chem Sci       Date:  2012-08-01       Impact factor: 9.825

Review 5.  Boron-substituted 1,3-dienes and heterodienes as key elements in multicomponent processes.

Authors:  Ludovic Eberlin; Fabien Tripoteau; François Carreaux; Andrew Whiting; Bertrand Carboni
Journal:  Beilstein J Org Chem       Date:  2014-01-22       Impact factor: 2.883

6.  Nano-Delivery of a Novel Inhibitor of Polynucleotide Kinase/Phosphatase (PNKP) for Targeted Sensitization of Colorectal Cancer to Radiation-Induced DNA Damage.

Authors:  Sams M A Sadat; Melinda Wuest; Igor M Paiva; Sirazum Munira; Nasim Sarrami; Forughalsadat Sanaee; Xiaoyan Yang; Marco Paladino; Ziyad Binkhathlan; Feridoun Karimi-Busheri; Gary R Martin; Frank R Jirik; David Murray; Armin M Gamper; Dennis G Hall; Michael Weinfeld; Afsaneh Lavasanifar
Journal:  Front Oncol       Date:  2021-12-23       Impact factor: 6.244

Review 7.  Natural products as an inspiration in the diversity-oriented synthesis of bioactive compound libraries.

Authors:  Christopher Cordier; Daniel Morton; Sarah Murrison; Adam Nelson; Catherine O'Leary-Steele
Journal:  Nat Prod Rep       Date:  2008-04-14       Impact factor: 13.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.